General Information |
|
Product |
TSLP Peptide |
Description |
Antigenic Blocking Peptide Thymic Stromal LymphoPoietin Antibody |
Verified Applications |
Immunodepletion, Immunocompetition |
Peptide Description |
Synthetic peptide taken within amino acid region 50-100 on human Thymic Stromal LymphoPoietin. |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Molecular Function |
cytokine activity interleukin-7 receptor binding |
Subcellular Location |
Extracellular region or secreted |
Expression |
Isoform 1 is expressed in a number of tissues including heart, liver and prostate. Isoform 2 is the predominant form in keratinocytes of oral mucosa, skin and in salivary glands. It is secreted into saliva. |
Structure |
Interacts with a receptor composed of CRLF2 and IL7R. Binding of TSLP to CRLF2/TSLPR is a mechanistic prerequisite for recruitment of IL7R to the high-affinity ternary complex. |
Alternative Nomenclature |
Thymic stromal lymphopoietin antibody Thymic stromal lymphopoietin protein TSLP antibody Tslp antibody TSLP protein antibody TSLP_HUMAN antibody |
Protein information supplied by UniProt.
Product | Note | Status | Price | |
---|---|---|---|---|
|
TSLP-101AP | |||
|
PC-TSLP | |||
|
TSLP-FITC | |||
|
TSLP-BIOTIN | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.